VaxGen and Raven to merge

Two South San Francisco biotech firms, the struggling VaxGen and Raven biotechnologies, inc., have agreed to merge in an all-shares transaction.

Shareholders in VaxGen, which has suffered a series of well-publicised setbacks including the failure of an AIDS vaccine in 2003, delisting from Nasdaq in 2004 and the loss of a U.S. government anthrax vaccine contract in 2006, will retain a majority of shares in the new company, the company said in a statement released Monday. Vaxgen will also assume the privately-held Raven’s debt and equipment lease obligations of approximately $1.8 million, and move its headquarters to Raven’s offices.

Vaxgen is required as part of the merger to relist with a national stock exchange, a step that company officials said is underway.

The merged company’s board will include four Vaxgen board members and three Raven board members. Raven CEO George F. Schreiner will serve as CEO and director of the new company, with Vaxgen President and CEO James P. Panek to serve as president and chief operating officer.

The combined company will have one compound for major cancer indications in clinical development, four oncology product candidates in preclinical development, and a library of antibodies to novel cancer antigens, the companies said in a statement.

businessBusiness & Real Estate

If you find our journalism valuable and relevant, please consider joining our Examiner membership program.
Find out more at www.sfexaminer.com/join/

Just Posted

Study: Banning cars on Market had minimal effect on side streets

A traffic nightmare. Congestions madness. Carmageddon. Those were the fears voiced by… Continue reading

Police Commission president calls for probe into allegations of ‘rampant’ anti-black bias in SFPD

A newly surfaced email alleging widespread anti-black bias in San Francisco’s police… Continue reading

Breed declares local emergency to counter threat of coronavirus

City officials warn against discrimination while they prepare for the possibility of an outbreak.

Educators warn of possible strike after district calls for budget cuts, layoffs

SFUSD faces up to $31.8 million shortfall in current school year

Sting builds tuneful ‘Last Ship’

Vivid score, great singers buoy pop star’s musical

Most Read